Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Definitely HUGE News and as things develop, $NMTC will rocket.
Looking good!
$NMTC News February 08, 2022
NeuroOne® Medical Technologies Corporation Releases Successful Long-Term Recording Test Data for its Novel Thin Film Platform Electrode Technology https://finance.yahoo.com/news/neuroone-medical-technologies-corporation-releases-140000500.html
Green heading into power hour!
Incredible day going higher today , must read article here: https://biotechmarketreporter.com/behind-the-miracle-therapies-of-neuroscience/?utm_source=bullzeyemedia&utm_medium=affiliate&utm_campaign=nmtcz_us&_ef_transaction_id=ffa7da52c5d14a5dbcaaf910f4958b4c
2 FDA-Cleared Devices and Counting!
Looking forward to seeing further News from the company on these opportunities.
We also believe that in the near term it may provide an opportunity to enter the research market as well as offering the potential for strategic licensing agreements in certain markets."
Huge volume yesterday and today it's trading over its 10-day average volume with more than 4 hours left in the day.
Super good day here! Trying to go over $2.50 again
https://biotechmarketreporter.com/behind-the-miracle-therapies-of-neuroscience/?utm_source=bullzeyemedia&utm_medium=affiliate&utm_campaign=nmtcz_us&_ef_transaction_id=ffa7da52c5d14a5dbcaaf910f4958b4c
Today there is a massive $13.6 billion neurostimulation devices market developing for the ongoing study of the vast arrays of the brain’s neural connections.
Such great development and break through, keep up with the nice updates!
Great day so far trading positively on today’s news!
Dave Rosa, CEO of NeuroOne commented, "We are excited with the results of our initial long-term testing of recording capabilities for our thin film electrode technology. These results support the potential expansion of utilization of these electrodes for long-term recording for indications such as epilepsy, Parkinson's disease, chronic back pain due to failed back surgeries, other related neurological disorders as well as research applications. We also believe that in the near term it may provide an opportunity to enter the research market as well as offering the potential for strategic licensing agreements in certain markets."
Feb. 8, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it successfully completed initial pre-clinical long-term testing of recording capabilities on its platform thin film electrode technology. In test procedures, the electrodes' ability to record electrical activity over a span of 5 years was measured using an accelerated aging test model. The test results demonstrated NeuroOne's thin film electrodes' reliability against environmental factors that may contribute to device failure or malfunction, which is a well-established challenge with thin film electrode technology.
Thin to the HOD on todays news
https://finance.yahoo.com/news/neuroone-medical-technologies-corporation-releases-140000500.html
Mayo Clinic began testing NeuroOne’s technology in preclinical models and clinical research in 2015 and is presently a top shareholder.
Good morning. A decent day yesterday, let's see if it can gain some traction today.
Huge opportunity for the company per the statement below.
Today there is a massive $13.6 billion neurostimulation devices market developing for the ongoing study of the vast arrays of the brain’s neural connections.
https://biotechmarketreporter.com/behind-the-miracle-therapies-of-neuroscience/?utm_source=bullzeyemedia&utm_medium=affiliate&utm_campaign=nmtcz_us&_ef_transaction_id=ffa7da52c5d14a5dbcaaf910f4958b4c
Good trading day yesterday, momentum shall continue this week
Be sure to read this article
https://biotechmarketreporter.com/behind-the-miracle-therapies-of-neuroscience/?utm_source=bullzeyemedia&utm_medium=affiliate&utm_campaign=nmtcz_us&_ef_transaction_id=ffa7da52c5d14a5dbcaaf910f4958b4c
It's trading 55% over its 10-day average volume within the last 15 minutes of the day...nice action.
Nice bids in power hour!
Going higher on the day, make sure you read the report
https://biotechmarketreporter.com/behind-the-miracle-therapies-of-neuroscience/?utm_source=bullzeyemedia&utm_medium=affiliate&utm_campaign=nmtcz_us&_ef_transaction_id=ffa7da52c5d14a5dbcaaf910f4958b4c
Yeah I saw that... that's an impressive partnership.
$2.21 hit earlier, and looking good. It's trading just under its 10-day average volume with less 2.5 hours left in the day.
NeuroOne has received FDA-approval for their Evo Cortical and sEEG Electrodes.
https://biotechmarketreporter.com/behind-the-miracle-therapies-of-neuroscience/?utm_source=bullzeyemedia&utm_medium=affiliate&utm_campaign=nmtcz_us&_ef_transaction_id=ffa7da52c5d14a5dbcaaf910f4958b4c
Trading decent volume to begin the day, UP almost 2%.
Article
Meet the Unsung Innovators Behind the Miracle Therapies of Neuroscience
https://biotechmarketreporter.com/behind-the-miracle-therapies-of-neuroscience/?utm_source=bullzeyemedia&utm_medium=affiliate&utm_campaign=nmtcz_us&_ef_transaction_id=ffa7da52c5d14a5dbcaaf910f4958b4c
Massive $13.6 billion neurostimulation devices market developing for the ongoing study of the vast arrays of the brain’s neural connections
The diagnostic electrode technology currently used to detect neurological disorders is the same that was developed way back in the 1960s.
https://biotechmarketreporter.com/behind-the-miracle-therapies-of-neuroscience/?utm_source=bullzeyemedia&utm_medium=affiliate&utm_campaign=nmtcz_us&_ef_transaction_id=ffa7da52c5d14a5dbcaaf910f4958b4c
Following this stock. What it does is unique and can benefit many patients out there!
Fade back to $2 almost complete. This might get interesting again.
NMTC moved to the Nasdaq from the OTC:
https://otce.finra.org/otce/dailyList?viewType=Deletions
South of $7 but not by much. Appears to be a bottom here.
Reverse splits without catalysts usually end bad. Not sure what NMTC is doing here. Back to $7.
NMTC one for 3 reverse split;
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
NeuroOne Medical Technologies Corporation
12,500,000 Shares of Common Stock Offered by Selling Securityholders
12,500,000 Warrants Offered by Selling Securityholders
12,500,000 Shares of Common Stock Issuable upon Exercise of Resold Warrants
This prospectus relates to the public offering by the selling securityholders listed on in this prospectus in the section entitled “Selling Securityholders” (the “Selling Securityholders”) of (i) 12,500,000 shares of our common stock, par value $0.001 per share (the “Common Stock”) of NeuroOne Medical Technologies Corporation (the “Company”) and (ii) warrants (“Warrants”) to purchase 12,500,000 shares of Common Stock (and the shares underlying the Warrants). We are registering these securities on behalf of the Selling Securityholders, to be offered and sold by them from time to time.
This prospectus also relates to the issuance by us of 12,500,000 shares of our Common Stock upon the exercise by third parties of Warrants that have been resold by the Selling Securityholders to permitted third parties under this prospectus (the “Resold Warrants”). The exercise price of each Warrant is $1.75 per share and are exercisable for a period of five years from the date of issuance. We are not selling any securities under this prospectus and we will not receive proceeds from the sale of Common Stock by the Selling Securityholders. However, we may receive proceeds from the cash exercise of the Warrants, which, if exercised in cash at the current applicable exercise price with respect to all of the 12,500,000 shares of Common Stock, would result in gross proceeds to the Company of $21.9 million.
Doing more research, liking this one so far
Followers
|
7
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
158
|
Created
|
01/11/14
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |